Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Endocrinology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Endocrinology Other
    PHD2 Mutation and Congenital Erythrocytosis with Paraganglioma - (N Engl J Med)
    Researchers Develop Screening Tool to Identify Patients With Prediabetes - (DGNews)
    Degarelix Quickly Reduces Testosterone Levels in Men With Prostate Cancer - (DGNews)
    FDA Approves Synthetic Conjugated Oestrogens-A Vaginal Cream for Vulvar, Vaginal Atrophy Symptoms - (DGNews)
    Vitamin K Linked to Insulin Resistance in Older Men - (DGNews)

    News archive

     Recent webcasts/CME - Endocrinology Other
    • Incretin-Based Therapy in Diabetes: Expanding Options and Providing Benefits
    • Assessing Recent Data on Incretin-Based Therapy in Diabetes
    • Can Treatments for Disordered Mineral Metabolism Reduce Adverse Outcomes in CKD?
    • Managing Hyperphosphatemia Improves Outcomes in Chronic Kidney Disease
    • Use of Progesterone in 3 Challenging Cases

      Webcasts/CME archive

       Recent cases - Endocrinology Other
        A Paraneoplastic Manifestation of Metastatic Breast Cancer Responding to Endocrine Therapy: A Case Report
        Progesterone Use in Assisted Reproductive Technology
        Fast Growing Pancreatic Neuroendocrine Carcinoma in a Multiple Endocrine Neoplasia Type 1 Patient: A Case Report
        Exacerbation of Hepatitis C Induced Subclinical Hypoadrenalism by Interferon-Alpha2beta: A Case Report
        Diabetic Fetopathy Associated with Bilateral Adrenal Hyperplasia and Ambiguous Genitalia: A Case Report

        Cases archive
          




        my personal edition > endocrinology other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Testosterone-Induced Muscle Growth Linked To Muscle Fibre Hypertrophy

        A DGReview of :"Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy"
        AJP: Endocrinology and Metabolism

        07/17/2002
        By David Loshak


        Increases in muscle volume when young men in good gonadal health are treated with graded doses of testosterone are due to the growth of muscle fibre.

        The increases are associated with concentration-dependent rises in cross-sectional areas of both type I and type II muscle fibres and myonuclear number, say specialists at the Charles R. Drew University of Medicine and Science, Los Angeles, California and Harbor-University of California at Los Angeles Medical Center, Torrance, California.

        The specialists noted that muscle size increased when replacement doses of testosterone were given to healthy hypogonadal men and supraphysiological doses were given to eugonadal men.

        To see if these increases were due to muscle fibre hypertrophy, the specialists gave monthly injections of a long-acting gonadotropin-releasing hormone agonist to suppress endogenous testosterone secretion to 61 healthy men aged 18-35 years. The men also received weekly injections of 25, 50, 125, 300 or 600 mg testosterone enanthate (TE) for 20 weeks.

        Thigh muscle volume was measured by magnetic resonance imaging. Muscle biopsies were taken from vastus lateralis muscle in 39 men before and after the 20 weeks.

        The combined treatment resulted in a mean nadir testosterone concentration of 234 ng/dl with the 25 mg dose. This rose to 289 ng/dl with 50 mg, to 695 ng/dl with 125 mg and to 1,344 ng/dl with 300 mg. The highest concentration, 2,435 ng/dl, was reached with 600 mg doses.

        Graded doses of testosterone administration were associated with testosterone dose and concentration-dependent increase in thigh muscle volume. Changes in cross-sectional areas of both type I and II fibres were dependent on testosterone dose and correlated significantly with total and free testosterone concentrations during treatment.

        The men who received 300 mg and 600 mg of testosterone enanthate weekly experienced significant increases from baseline in areas of type I muscle fibres. Those in the 600 mg group had significant rises in cross-sectional area of type II fibres also.

        The relative proportions of type I and type II fibres did not change significantly after treatment in any group.

        The myonuclear number per fibre increased significantly in men on the two highest doses of testosterone enanthate and correlated significantly with testosterone concentration and muscle fibre cross-sectional area.
        Endocrinology and Metabolism 2002;283(1):E154-E164. "Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send